Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh · Delayed Price · Currency is BDT 223.60
+1.30 (0.58%)
At close: Jul 6, 2026
DSE:SQURPHARMA Market Cap
DSE:SQURPHARMA has a market cap or net worth of 198.21 billion as of July 6, 2026. Its market cap has increased by 8.02% in one year.
Market Cap
198.21B
Enterprise Value
126.00B
Revenue
83.53B
Ranking
n/a
PE Ratio
7.66
Stock Price
223.60
Market Cap Chart
Since April 18, 2002, DSE:SQURPHARMA's market cap has increased from 3.10B to 198.21B, an increase of 6,288.74%. That is a compound annual growth rate of 18.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 198.21B | 12.59% |
| Dec 30, 2025 | 176.05B | -8.77% |
| Dec 30, 2024 | 192.98B | 3.52% |
| Dec 28, 2023 | 186.42B | 0.24% |
| Dec 29, 2022 | 185.98B | -2.10% |
| Dec 30, 2021 | 189.97B | -2.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beximco Pharmaceuticals PLC. | 64.82B |
| Renata | 52.35B |
| Unilever Consumer Care | 39.88B |
| Beacon Pharmaceuticals | 25.69B |
| The ACME Laboratories | 17.48B |
| Asiatic Laboratories | 16.34B |
| The IBN SINA Pharmaceutical Industry | 9.91B |
| Navana Pharmaceuticals | 7.69B |